These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19248764)

  • 1. Spectral properties and mechanisms that underlie autofluorescent accumulations in Batten disease.
    Seehafer SS; Pearce DA
    Biochem Biophys Res Commun; 2009 May; 382(2):247-51. PubMed ID: 19248764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. You say lipofuscin, we say ceroid: defining autofluorescent storage material.
    Seehafer SS; Pearce DA
    Neurobiol Aging; 2006 Apr; 27(4):576-88. PubMed ID: 16455164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular models of Batten disease.
    Minnis CJ; Thornton CD; FitzPatrick LM; McKay TR
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165559. PubMed ID: 31655107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
    Kida E; Golabek AA; Wisniewski KE
    Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders.
    Elleder M; Sokolová J; Hrebícek M
    Acta Neuropathol; 1997 Apr; 93(4):379-90. PubMed ID: 9113203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathomechanisms in the neuronal ceroid lipofuscinoses.
    Nelvagal HR; Lange J; Takahashi K; Tarczyluk-Wells MA; Cooper JD
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165570. PubMed ID: 31678162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs).
    Holopainen JM; Saarikoski J; Kinnunen PK; Järvelä I
    Eur J Biochem; 2001 Nov; 268(22):5851-6. PubMed ID: 11722572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses.
    Mukherjee AB; Appu AP; Sadhukhan T; Casey S; Mondal A; Zhang Z; Bagh MB
    Mol Neurodegener; 2019 Jan; 14(1):4. PubMed ID: 30651094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCLs and ER: A stressful relationship.
    Marotta D; Tinelli E; Mole SE
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1273-1281. PubMed ID: 28390949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Batten disease (Neuronal ceroid lipofuscinoses)--accumulation of ATP synthase subunit c caused by the delay of lysosomal degradation].
    Ezaki J; Kominami E
    Nihon Rinsho; 1995 Dec; 53(12):3055-61. PubMed ID: 8577058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
    Kollmann K; Uusi-Rauva K; Scifo E; Tyynelä J; Jalanko A; Braulke T
    Biochim Biophys Acta; 2013 Nov; 1832(11):1866-81. PubMed ID: 23402926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary fibroblasts from CSPα mutation carriers recapitulate hallmarks of the adult onset neuronal ceroid lipofuscinosis.
    Benitez BA; Sands MS
    Sci Rep; 2017 Jul; 7(1):6332. PubMed ID: 28740222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical aspects of neuronal ceroid lipofuscinoses.
    Tyynelä J; Suopanki J
    Neurol Sci; 2000; 21(3 Suppl):S21-5. PubMed ID: 11073224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.
    Marques ARA; Di Spiezio A; Thießen N; Schmidt L; Grötzinger J; Lüllmann-Rauch R; Damme M; Storck SE; Pietrzik CU; Fogh J; Bär J; Mikhaylova M; Glatzel M; Bassal M; Bartsch U; Saftig P
    Autophagy; 2020 May; 16(5):811-825. PubMed ID: 31282275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cln1 gene disruption in mice reveals a common pathogenic link between two of the most lethal childhood neurodegenerative lysosomal storage disorders.
    Chandra G; Bagh MB; Peng S; Saha A; Sarkar C; Moralle M; Zhang Z; Mukherjee AB
    Hum Mol Genet; 2015 Oct; 24(19):5416-32. PubMed ID: 26160911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).
    Kim WD; Wilson-Smillie MLDM; Thanabalasingam A; Lefrancois S; Cotman SL; Huber RJ
    Front Cell Dev Biol; 2022; 10():812728. PubMed ID: 35252181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal ceroid depletion by drugs: therapeutic implications for a hereditary neurodegenerative disease of childhood.
    Zhang Z; Butler JD; Levin SW; Wisniewski KE; Brooks SS; Mukherjee AB
    Nat Med; 2001 Apr; 7(4):478-84. PubMed ID: 11283676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses.
    Butz ES; Chandrachud U; Mole SE; Cotman SL
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165571. PubMed ID: 31678159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lipid-linked oligosaccharide accumulation in mouse models of Batten disease.
    Cho SK; Gao N; Pearce DA; Lehrman MA; Hofmann SL
    Glycobiology; 2005 Jun; 15(6):637-48. PubMed ID: 15647513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.